Applying proteomic technology to clinical virology

Developing antiviral drugs, vaccines and diagnostic markers is still the most ambitious challenge in clinical virology. In the past few decades, data from high‐throughput technologies have allowed for the rapid development of new antiviral therapeutic strategies, thus making a profound impact on tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancone, C., Ciccosanti, F., Montaldo, C., Perdomo, A. B., Piacentini, M., Alonzi, T., Fimia, G. M., Tripodi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Themed Section
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129767/
https://www.ncbi.nlm.nih.gov/pubmed/23034105
http://dx.doi.org/10.1111/1469-0691.12029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129767/
https://www.ncbi.nlm.nih.gov/pubmed/23034105
http://dx.doi.org/10.1111/1469-0691.12029

Ejemplares similares